HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shan Hu Selected Research

Shan Hu Research Topics

Disease

11Neoplasms (Cancer)
01/2022 - 06/2012
5Polyuria
01/2022 - 01/2018
5Nephrogenic Diabetes Insipidus
01/2019 - 10/2016
4Breast Neoplasms (Breast Cancer)
11/2020 - 06/2012
4Pain (Aches)
03/2020 - 06/2012
4Cardiomegaly (Heart Hypertrophy)
01/2019 - 01/2017
3Lung Neoplasms (Lung Cancer)
01/2022 - 11/2019
3Bipolar Disorder (Manic Depressive Psychosis)
12/2021 - 01/2021
3Infections
03/2021 - 05/2020
3Hypoxia (Hypoxemia)
01/2021 - 01/2021
3Hyperalgesia
01/2015 - 06/2012
2Multiple Sclerosis
01/2022 - 02/2014
2Kidney Diseases (Kidney Disease)
01/2021 - 11/2018
2Reperfusion Injury
01/2021 - 01/2021
2Neoplasm Metastasis (Metastasis)
01/2020 - 11/2019
2Ureteral Obstruction
01/2019 - 01/2019
2Dehydration (Water Stress)
01/2019 - 10/2016
2Hypertrophy
12/2018 - 01/2017
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2022
1Dysbiosis
04/2022
1Obesity
04/2022
1Intrahepatic Cholestasis
01/2022
1Frailty
01/2022
1Wilms Tumor 3
01/2022
1Myasthenia Gravis
01/2022
1Gestational Diabetes (Gestational Diabetes Mellitus)
01/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Rectal Neoplasms (Rectal Cancer)
01/2022
1Adenocarcinoma of Lung
01/2022
1Colorectal Neoplasms (Colorectal Cancer)
11/2021
1Inflammatory Bowel Diseases (Inflammatory Bowel Disease)
11/2021
1Sarcoma (Soft Tissue Sarcoma)
04/2021
1Pneumonia (Pneumonitis)
03/2021
1Lymphoma (Lymphomas)
01/2021
1Shock
01/2021
1ST Elevation Myocardial Infarction
01/2021
1Ischemia
01/2021
1Inflammation (Inflammations)
01/2021
1Hyperuricemia
01/2021
1Out-of-Hospital Cardiac Arrest
01/2021
1Myocarditis (Carditis)
01/2021
1Mycoses (Diseases, Fungus)
01/2021

Drug/Important Bio-Agent (IBA)

9Proteins (Proteins, Gene)FDA Link
01/2022 - 11/2014
5LithiumIBA
01/2019 - 10/2016
4Aquaporin 2IBA
01/2021 - 10/2016
4CytokinesIBA
01/2020 - 12/2012
3MicroRNAs (MicroRNA)IBA
01/2022 - 01/2019
37,7'- dimethoxy- (4,4'- bi- 1,3- benzodioxole)- 5,5'- dicarboxylic acid dimethyl ester (BDD)IBA
12/2021 - 01/2021
3Angiotensin IIIBA
10/2018 - 11/2014
2Indicators and Reagents (Reagents)IBA
01/2022 - 01/2022
2Biomarkers (Surrogate Marker)IBA
01/2022 - 01/2022
2RNA (Ribonucleic Acid)IBA
01/2022 - 01/2022
2Long Noncoding RNAIBA
01/2022 - 01/2019
2Aquaporins (Water Channels)IBA
01/2021 - 01/2019
2Bile Acids and Salts (Bile Acids)IBA
01/2021 - 11/2018
2Therapeutic UsesIBA
10/2019 - 01/2019
2TamoxifenFDA LinkGeneric
01/2019 - 01/2018
2Messenger RNA (mRNA)IBA
12/2018 - 11/2014
2AngiotensinsIBA
10/2018 - 11/2014
2TOR Serine-Threonine KinasesIBA
08/2018 - 11/2015
2Phosphotransferases (Kinase)IBA
01/2017 - 11/2015
2Analgesics (Analgesic Drugs)IBA
01/2015 - 06/2012
13,4-dihydroxyphenylpyruvic acidIBA
09/2022
1Anti-Bacterial Agents (Antibiotics)IBA
04/2022
1PrebioticsIBA
04/2022
1GlucansIBA
04/2022
1Volatile Fatty AcidsIBA
04/2022
1Dietary FiberFDA Link
04/2022
1LipopolysaccharidesIBA
04/2022
1RNA Precursors (Precursor, mRNA)IBA
01/2022
1Fatty Acids (Saturated Fatty Acids)IBA
01/2022
1Competitive Endogenous RNAIBA
01/2022
1RGFP966IBA
01/2022
1ErbB Receptors (EGF Receptor)IBA
04/2021
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
04/2021
1Nucleic AcidsIBA
03/2021
1Chimeric Antigen ReceptorsIBA
01/2021
1protein kinase modulatorIBA
01/2021
1Cystatin CIBA
01/2021
1N- (2- (4- bromocinnamylamino)ethyl)- 5- isoquinolinesulfonamide (h89)IBA
01/2021
1Natriuretic PeptidesIBA
01/2021
1roxadustatIBA
01/2021
1AntigensIBA
01/2021
1GTP-Binding Proteins (G-Protein)IBA
01/2021
1piperineIBA
01/2021
14- benzyl- 2- methyl- 1,2,4- thiadiazolidine- 3,5- dioneIBA
01/2021
1Lithocholic AcidIBA
01/2021
1Hydroxybutyrate Dehydrogenase (3 Hydroxybutyrate Dehydrogenase)IBA
01/2021
1GW 4869IBA
01/2021
1Lysine (L-Lysine)FDA Link
01/2021
1Interleukin-18 (Interleukin 18)IBA
01/2021
1Coloring Agents (Dyes)IBA
01/2021
1Pharmaceutical PreparationsIBA
01/2021
1VimentinIBA
11/2020
1Cadherins (E-Cadherin)IBA
11/2020
1Oxygen (Dioxygen)IBA
05/2020

Therapy/Procedure

6Therapeutics
01/2022 - 11/2015
1Immunotherapy
01/2022
1Thymectomy
01/2022
1Contraindications
11/2021